SCHEMBL16623583

SCHEMBL16623583

CC(=O)N1CCC(c2ccc(C(=N)c3c(Nc4c(F)cccc4F)cc[nH]c3=O)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.42
ALDH1A1 P00352 2/20 0.38
JAK1 P23458 1/20 0.37
ZAP70 P43403 1/20 0.36
QDPR P09417 2/20 0.36
BTK Q06187 2/20 0.35
CCR1 P32246 5/20 0.35
ADAMTS5 Q9UNA0 1/20 0.33
SYK P43405 1/20 0.33
MCHR1 Q99705 1/20 0.33
KDM4E B2RXH2 1/20 0.33
BRD4 O60885 1/20 0.33
POLB P06746 1/20 0.33
CREBBP Q92793 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623578 0.84 EGFR (0.35) EGFRJAK1ZAP70
SCHEMBL17849239 0.78 HDAC1 (0.46) EGFRALDH1A1JAK1POLBHDAC3
SCHEMBL16623511 0.77 TYK2 (0.38)
SCHEMBL16623503 0.76 EGFR (0.35) EGFRJAK1
SCHEMBL16623558 0.76 PARP1 (0.34)
SCHEMBL17849188 0.76 EGFR (0.40) EGFRALDH1A1JAK1ZAP70HDAC3
SCHEMBL17849249 0.76 EGFR (0.40) EGFRALDH1A1JAK1
SCHEMBL18052623 0.75 EGFR (0.36) EGFRJAK1
SCHEMBL17849248 0.75 EGFR (0.41) EGFRALDH1A1JAK1
SCHEMBL16623568 0.74 EGFR (0.38) EGFRJAK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed